CD45 Monoclonal Antibody (OX1), PE, eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0461511
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $213.75
About this award
Life Technologies Corporation was awarded contract A207_PO-0461511 by the University of Virginia on July 24, 2026, with a cumulative contract value of $213.00. The prime contractor will deliver one unit of CD45 Monoclonal Antibody (OX1), PE (phycoerythrin), manufactured under the eBioscience product line. The deliverable will be provided to Jie Li at the University of Virginia in Virginia.
This contract represents a single-line-item procurement for laboratory reagent materials, with the unit price established at $213.75. The award reflects the University of Virginia's procurement activity for research or diagnostic applications requiring this specific monoclonal antibody product. No additional performance period details beyond the award date of July 24, 2026, are specified in the contract documentation provided.
Line items
| Item | Total |
|---|---|
| CD45 Monoclonal Antibody (OX1), PE, eBioscience | $213.75 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0461511?
Contract A207_PO-0461511 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on July 24, 2026.
How much is contract A207_PO-0461511 worth?
Its cumulative value is $213.75.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award